A novel schizophrenia drug. Later in the year, the FDA will review a new drug treatment for schizophrenia the first for the psychiatric condition in decades. Karuna Therapeutics has improved
A novel schizophrenia drug. Later in the year, the FDA will review a new drug treatment for schizophrenia the first for the psychiatric condition in decades. Karuna Therapeutics has improved
A novel schizophrenia drug. Later in the year, the FDA will review a new drug treatment for schizophrenia the first for the psychiatric condition in decades. Karuna Therapeutics has improved
If the agency gives KarXT the green light, the drug will be the first truly new treatment for schizophrenia in decades.
A novel schizophrenia drug. Later in the year, the FDA will review a new drug treatment for schizophrenia the first for the psychiatric condition in decades. Karuna Therapeutics has improved
A novel schizophrenia drug. Later in the year, the FDA will review a new drug treatment for schizophreniathe first for the psychiatric
CLOZAPINE IS THE DRUG OF CHOICE for treatment resistant schizophrenia. It is one of the few drugs in New Zealand that can not be prescribed by
new personalized medications that avoid the side effects of current treatments for schizophrenia Schizophrenia is often treated with drugs
Researchers are developing new schizophrenia medications that promise better treatment of the disorder. Learn what new schizophrenia treatments are coming on
Comments